It is now more than two years since pentamethonium and hexamethonium salts were first used in the treatment of essential hypertension. Hexamethonium has proved more useful and more popular than pentamethonium, and, despite the views of Iyocket and his co-workers (1950) that the hypotensive effect was principally due to the bromide ion of the original salt, the results of trials with hexamethonium bi-tartrate (' Vegolysen-T') (Campbell et al., 1952) seem to confirm that it is methonium itself which lowers the blood pressure. Smirk and Alstad (1951) and more recently, McMichael (1952) have shown most convincingly that parenteral or combined oral and parenteral administration afford considerable control of blood pressure with few side-effects, particularly in relation to the gastro-intestinal tract. Oral administration alone has been even more extensively tried by different workers (Campbell & Robertson, 1950 ; Murphy, 1951 ; Campbell et al., 1952) , with varying degrees of success.
The purpose of this paper is to present experiences gained in the use of oral hexamethonium therapy in essential hypertension over a period extending in some cases to two years and to review the fate of 50 such cases who were regarded on prima facie evidence as suitable candidates for methonium therapy. The results are presented in 33 cases treated over periods ranging from 3 to 24 months, 15 of which cases are still under treatment.
MATERIA^ AND PRELIMINARY INVESTIGATIONS.
The series to be reviewed consists of 50 cases of essential hypertension referred or selected as candidates for methonium therapy. There were twelve male and thirty-eight female cases, ranging in age from 32 to 66 (average age 49.9 years). All these patients, when first seen, had troublesome symptoms and a diastolic pressure of at least 110 mm. Hg. With one exception, all were admitted to hospital for thorough initial investigation including a cardio-vascular survey, assessment of renal function, exclusion, so far as possible, of unilateral renal disease and the recording of fundal pathology. The cases were then given a grouping according to the standards of Keith et al. (1939) as modified by Palmer et al. (1948) There is no real proof that a fall of blood pressure will necessarily precipitate a cardiovascular of cerebral thrombotic incident and there is support for using the drug even in the presence of a history of small cerebral incidents (Rosenheim, 1952 
